Ardsley Advisory Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-3,000
| Closed | -$370K | – | 130 |
|
|
2020
Q2 | $370K | Buy |
+3,000
| New | +$370K | 0.08% | 83 |
|
|
2018
Q2 | – | Sell |
-10,000
| Closed | -$811K | – | 143 |
|
|
2018
Q1 | $811K | Hold |
10,000
| – | – | 0.12% | 64 |
|
|
2017
Q4 | $892K | Buy |
10,000
+3,000
| +43% | +$268K | 0.11% | 69 |
|
|
2017
Q3 | $651K | Hold |
7,000
| – | – | 0.09% | 77 |
|
|
2017
Q2 | $636K | Sell |
7,000
-82,500
| -92% | -$7.5M | 0.1% | 69 |
|
|
2017
Q1 | $7.86M | Buy |
+89,500
| New | +$7.86M | 1.22% | 23 |
|
|
2016
Q4 | – | Sell |
-2,500
| Closed | -$231K | – | 124 |
|
|
2016
Q3 | $231K | Buy |
+2,500
| New | +$231K | 0.04% | 117 |
|
|
2016
Q1 | – | Sell |
-2,500
| Closed | -$262K | – | 135 |
|
|
2015
Q4 | $262K | Buy |
+2,500
| New | +$262K | 0.03% | 102 |
|